The effects of HIV-1 tat protein on cell cycle during cervical carcinogenesis

Cancer Biology and Therapy

Volumn 5, Issue 6, 2006, Pages 684-690

  Nyagol, J ^a,c   Leucci, E ^a   Onnis, A ^a   De Falco, G ^a,b   Tigli, C ^a   Sanseverino, F ^a   Torriccelli, M ^a   Palummo, N ^a   Pacenti, L ^a   Santopietro, R ^a   Spina, D ^a   Gichangi, P ^d   Muchiri, L ^d   Lazzi, S ^a   Petraglia, F ^a   Leoncini, L ^a   Giordano, A ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b Temple University   (United States)

^c Nairobi Hospital   (Kenya)

^d UNIVERSITY OF NAIROBI   (Kenya)

Author keywords

Cell cycle regulators; Cervical cancer; HIV 1; HPV; Tat; Tumor biology; Tumor suppressor genes

Indexed keywords

BIOLOGICAL MARKER; CYCLIN A; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN P130; PROTEIN P16; PROTEIN P21; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR E2F; VIRUS PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRECANCER; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATOR GENE; TRANSCRIPTION REGULATION; UTERINE CERVIX CANCER; WART VIRUS;

EID: 33745804728     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.5.6.2907     Document Type: Article

References (46)

1. Clarke B and Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. J Mol Pathol 2002; 55:19-24.
2. Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol. 1992; 79:328-37.
3. 6-integrin as a candidate receptor for papillomaviruses. J virol 1997; 71:2449-56.
4. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M. Human papilloma virus infection requires cell surface heparan sulphate. J virol 2001; 75:1565-70.
5. Chow LT, Broker TR. Papilloma virus DNA replication. Intervirology 1994; 37:150-8.
6. Braun K, Ehemann V, Waldeck W, Pipkorn R, Corban-Wilhelm H, Jenne J, Gissmann L, Debus J. HPV18 E6 and E7 genes affect cell cycle, pRB and p53 of cervical tumor cells and represent prominent candidates for intervention by use peptide nucleic acids (PNAs). Cancer Lett. 2004; 209:37-49.
7. Sheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63:1129-36.
8. Dyson N, Howley PM, Munger K, Harlow E. The human papillomavirus 16 E7 oncoprotein is able to bind the retinoblastoma gene product. Science 1989; 243:934-37.
9. Massad LS, Turyk ME, Bitterman P, Wilbanks GD. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers. Gynecol Oncol 1996; 60:428-34.
10. Vernon SD, Hart CE, Reeves WC, Icenogle JP. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 1993; 27:133-45.
11. Kapiga SH, Msamanga GI, Spiegelman D, Mwakyoma H, Fawzi WW, Hunter DJ. Risk factors for cervical squamous intraepithelial lesions among HIV-1 seropositive women in Dar es Salaam, Tanzania. Int J Gynaecol Obstet 1999; 67:87-94.
12. Tornesello ML, Buonaguro FM, Beth-Giraldo E, Giraldo G. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 1993; 36:57-64.
13. Palefsky JM, Minkoff H, Kalish LA, Levine A, Sacks HS, Garcia P, Young M, Melnick S, Miotti P, Burk R. Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women. J Natl Cancer Inst 1999; 91:226-36.
14. Walker F, Adle-Biassette H, Madelenat P, Henin D, Lehy T. Increased apoptosis in cervical intraepithelial neoplasia associated with HIV infection: implication of oncogenic human papillomavirus, caspases, and Langerhans cells. Clin Cancer Res 2005; 11:2451-8.
15. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. J Virol 2003; 77:1551-63.
16. Buonauguro FM, Tornesello ML, Buonauguro L, Del Gaudio E, Beth-Giraldo E, Giraldo G. Role of HIV as cofactor in HPV oncogenesis:in vitro evidence of virus interactions. Antibiot Chemother 1994; 46:102-09.
17. Aoki Y, and Tosato. Neoplastic Conditions in the context of HIV infection. Current HIV Research 2004; 2: 343-49.
18. Levi JE, Fernandes S, Tateno AF. Presence of multiple human papillomavirus types in cervical samples from HIV-infected women. Gynecol Oncol 2004; 92:225-31.
19. Russo G, Zamparelli A, Howard CM, Minimo C, Bellan C, Carillo G, Califano L, Leoncini L, Giordano A, Claudio PP. Expression of cell cycle-regulated proteins pRB2/p130, p107, E2F4, p27, and pCNA in salivary gland tumors: prognostic and diagnostic implications. Clin Cancer Res 2005; 11:3265-73.
20. Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J. Cyclin E-induced S phase without activation of the pRb/E2F pathway. Genes Dev 1997; 11:1479-92.
21. Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T. The role of Human papilloma virus in the molecular biology of cervical carcinogenesis. J Med Sci 2004; 50: 9-19.
22. Wu Y, Chen Y, Li L, Yu G, Zhang Y, He Y. Associations of high-risk HPV types and viral load with cervical cancer in China. J Clin Virol 2006; 35:264-69.
23. Hawes SE, Critchlow CW, Faye Niang MA, Diouf MB, Diop A, Toure P, Aziz Kasse A, Dembele B, Salif Sow P, Coll-Seck AM, Kuypers JM, Kiviat NB. Increased risk of high-grade cervical squamous intraepithelial lesions and invasive cervical cancer among African women with human immunodeficiency virus type 1 and 2 infections. J Infect Dis 2003; 188:555-63.
24. Vanegas M, Llano M, Delgado S, Thompson D, Peretz M, Poeschla E. Identification of the LEDGF/p75 HIV-1 integrase-interaction domain and NLS reveals NLS-independent chromatin tethering. J Cell Sci 2005; 118:1733-43.
25. Albini A, Soldi R, Giunciuglio D, Giraudo E, Benelli R, Primo L, Noonan D, Salio M, Camussi G, Rockl W, Bussolino F. The angiogenesis induced by HIV-1 tat protein is mediated by the Flk-1/KDR receptor on vascular endothelial cells Nature Med 1996; 2:1371-75.
26. Bellan C, De Falco G, Lazzi S, Leoncini L. Pathologic aspects of AIDS malignancies. Oncogene 2003; 22:6639-45.
27. Wang HL, Lu DW. Detection of human papillomavirus DNA and expression of p16, Rb, and p53 proteins in small cell carcinomas of the uterine cervix. Am J Surg Pathol 2004; 28:901-8.
28. Polyak K, Lee M-H, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, Massague J. p27Kip1, a cyclin-cdk inhibitor, links transforming growth factor-_ and contact inhibition to cycle cycle arrest. Genes Dev 1994; 8:9-22.
29. Snyder EL, Meade BR, Dowdy SF. Anti-cancer protein transduction strategies: reconstitution of p27 tumor suppressor function. J Control Release 2003; 91:45-51.
30. Strickler HD, Palefsky JM, Shah KV, Anastos K, Klein RS, Minkoff H, Duerr A, Massad LS, Celentano DD, Hall C, Fazzari M, Cu-Uvin S, Bacon M, Schuman P, Levine AM, Durante AJ, Gange S, Melnick S, Burk RD. Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst 2003; 95:1062-71.
31. La Ruche G, You B, Mensah-Ado I, Bergeron C, Montcho C, Ramon R, Toure-Coulibaly K, Welffens-Ekra C, Dabis F, Orth G. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia-neoplasia in African women. Int J Cancer 1998; 76:480-6.
32. Regulier EG, Reiss K, Khalili K, Amini S, Zagury JF, Katsikis PD, Rappaport J. T-cell and neural apoptosis in HIV infection: implication for therapeutic intervention. Int Rev Immunol 2004; 23:25-59.
33. Luker GD, Leib DA. Luciferase real-time bioluminescence imaging for the study of viral pathogenesis. Methods Mol Biol 2005; 292:285-96.
34. Bettaccini AA, Baj A, Accolla RS, Basolo F, Toniolo AQ. Proliferative activityof extracellular HIV-1 Tat protein in human epithelial cells: expression profile of pathogenically relevant genes. BMC Microbiol 2005; 5:20.
35. Girard F, Strausfeld U, Fernandez A, Lamb NJ. Cyclin A is required for the onset of DNA replication in mammalian fibroblast. Cell 1991; 67:1169-79.
36. Pagano M, Pepperkok R, Verde F, Ansorge W, Draetta G. Cyclin A is required at two points in the human cell cycle. EMBO J 1992; 11:962-72.
37. Minshull J, Blow JJ, Hunt T. Translation of cyclin mRNA is necessary for extracts of activated Xenopus eggs to enter mitosis. Cell 1989; 56:947-56.
38. Lehner CF, O'Farrel PH. Expression and function of Drosophila cyclin A during embryonic cell cycle progression. Cell 1989; 56:957-68.
39. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9:1149-63.
40. Conaldi PG, Bottelli A, Baj A, Serra C, Fiore L, Federico G, Bussolati B, Camussi G. Human immunodeficiency virus-1 tat induces hyperproliferation and dysregulation of renal glomerular epithelial cells. Am J Pathol 2002; 161:53-61.
41. Muller H and Helin k. The E2F transcription factors: Key regulators of cell proliferation. Biochim Biophys Acta 2000; M:1-12.
42. Ambrosino C, Palmieri C, Puca A, Trimboli F, Schiavone M, Olimpico F, Ruocco MR, di Leva F, Toriello M, Quinto I, Venuta S, Scala G. Physical and functional interaction of HIV-1 Tat with E2F-4, a transcriptional regulator of mammalian cell cycle. J Biol Chem 2002; 277:31448-58.
43. Suske G. The Sp-family of transcription factors. Gene 1999; 238:291-300.
44. Bartusel T, Schubert S and Klempnauer KH. Regulation of the cyclin D1 and Cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites. Gene 2005; 351:171-80.
45. Muller C, Yang R, Beck-von-Peccoz L, Idos G, Verbeek W, Koeffler HP. Cloning of the cyclin A1 genomic structure and characterization of the promoter region. J Biol Chem 1999; 274:11220-28.
46. Seve M, Favier A, Osman M, Hernandez D, Vaitaitis G, Flores NC, McCord JM, Flores SC. The human immunodeficiency virus-1 Tat protein increases cell proliferation, alters sensitivity to zinc chelator- induced apoptosis, and changes Sp1 DNA binding in HeLa cells. Arch Biochem Biophys 1999; 361:165-72.